Form 8-K - Current report:
SEC Accession No. 0001683168-25-006659
Filing Date
2025-09-03
Accepted
2025-09-03 17:00:45
Documents
15
Period of Report
2025-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT aclarion_8k.htm   iXBRL 8-K 44734
2 EMPLOYMENT AGREEMENT - GREGORY GOULD aclarion_ex1001.htm EX-10.1 85662
3 PRESS RELEASE DATED SEPTEMBER 3, 2025 aclarion_ex9901.htm EX-99.1 12482
  Complete submission text file 0001683168-25-006659.txt   382471

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE acon-20250902.xsd EX-101.SCH 3787
5 XBRL DEFINITION FILE acon-20250902_def.xml EX-101.DEF 26647
6 XBRL LABEL FILE acon-20250902_lab.xml EX-101.LAB 36764
7 XBRL PRESENTATION FILE acon-20250902_pre.xml EX-101.PRE 25271
17 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_8k_htm.xml XML 5794
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 251290746
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)